This document is an excerpt from the EUR-Lex website
Document 62024TN0312
Case T-312/24: Action brought on 24 June 2024 – Real Pharm Group v EUIPO – real (REAL PHARM)
Case T-312/24: Action brought on 24 June 2024 – Real Pharm Group v EUIPO – real (REAL PHARM)
Case T-312/24: Action brought on 24 June 2024 – Real Pharm Group v EUIPO – real (REAL PHARM)
OJ C, C/2024/4862, 12.8.2024, ELI: http://data.europa.eu/eli/C/2024/4862/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
Official Journal |
EN C series |
|
C/2024/4862 |
12.8.2024 |
Action brought on 24 June 2024 – Real Pharm Group v EUIPO – real (REAL PHARM)
(Case T-312/24)
(C/2024/4862)
Language in which the application was lodged: English
Parties
Applicant: Real Pharm Group sp. z o.o. (Czaplinek, Poland) (represented by: A.-M. Sobczak, lawyer)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: real GmbH (Mönchengladbach, Germany)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union figurative mark REAL PHARM – Application for registration No 18 608 282
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the First Board of Appeal of EUIPO of 24 April 2024 in Case R 1376/2023-1
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
alter the contested decision and declare the appeal justified and the opposition unfounded in its entirety; |
|
— |
order the reimbursement of its costs according to prescribed standards. |
Pleas in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
|
— |
Infringement of Article 18 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |
ELI: http://data.europa.eu/eli/C/2024/4862/oj
ISSN 1977-091X (electronic edition)